OXOS Medical, Inc. – Trademark Portfolio
Entity Type: 03
OXOS Medical, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include O, OXOS, and MICRO C. The owner is based in Atlanta, GA.
1100 Peachtree Street NE
Suite 700
Atlanta, GA 30309
Showing of trademarks Trademarks
Trademark Classifications
OXOS Medical, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does OXOS Medical, Inc. have?
OXOS Medical, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending.
What trademark classes does OXOS Medical, Inc. file in?
OXOS Medical, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 37 (Building & Construction), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are OXOS Medical, Inc.'s most well-known trademarks?
OXOS Medical, Inc.'s registered trademark portfolio includes well-known marks such as O, OXOS, and MICRO C. These are among 4 currently registered trademarks in the portfolio.
What is OXOS Medical, Inc.'s trademark registration success rate?
OXOS Medical, Inc. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.